Aclarion (ACON) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free ACON Stock Alerts $0.32 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 12:01 AM | msn.comACON Stock Earnings: Aclarion Reported Results for Q1 2024May 11, 2024 | americanbankingnews.comAclarion, Inc. (NASDAQ:ACON) Sees Significant Increase in Short InterestMay 9, 2024 | americanbankingnews.comAclarion (NASDAQ:ACON) Trading 6.9% Higher April 25, 2024 | globenewswire.comAclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainApril 23, 2024 | finance.yahoo.comAclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 2, 2024 | benzinga.comWhy Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionMarch 4, 2024 | finance.yahoo.comAclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsFebruary 27, 2024 | globenewswire.comAclarion Announces Closing of $3.0 Million Public OfferingFebruary 26, 2024 | msn.comWhy Aclarion (ACON) Shares Are Down Over 60% TodayFebruary 26, 2024 | globenewswire.comAclarion Announces Pricing of $3.0 Million Public OfferingFebruary 26, 2024 | investorplace.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 26, 2024 | investorplace.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 1, 2024 | benzinga.comAclarion Stock (NASDAQ:ACON), Short Interest ReportJanuary 30, 2024 | benzinga.comAclarion Stock (NASDAQ:ACON) Dividends: History, Yield and DatesJanuary 22, 2024 | markets.businessinsider.comEQS-News: Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 22, 2024 | markets.businessinsider.comAclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 8, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 5, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 11:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 07:01 PM with a stated reason of "News pending."January 3, 2024 | ca.finance.yahoo.comACLARION INC. DL-,00001 (IT2.BE)January 2, 2024 | finance.yahoo.comAclarion Announces Reverse Stock SplitNovember 27, 2023 | finance.yahoo.comAclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNovember 9, 2023 | finance.yahoo.comAclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan AdoptionNovember 6, 2023 | markets.businessinsider.comAclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MDOctober 25, 2023 | finance.yahoo.comAclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to DenverOctober 24, 2023 | finance.yahoo.comAclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM MeetingOctober 2, 2023 | finance.yahoo.comAclarion Provides Updated Investor Presentation and Corporate UpdateSeptember 8, 2023 | barrons.comAclarion Inc.August 25, 2023 | finance.yahoo.comAclarion, Inc. Announces Filing of Delayed 10-Q Quarterly ReportJune 14, 2023 | finance.yahoo.comAclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MIJune 8, 2023 | benzinga.comWhy Aclarion Stock Is Popping TodayJune 8, 2023 | msn.comACON Skyrockets after Presentation of Nociscan AbstractJune 8, 2023 | finance.yahoo.comAclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual MeetingMay 30, 2023 | finance.yahoo.comAclarion Announces New Engagement with The London Clinic and London Spine ClinicMay 23, 2023 | finance.yahoo.comAclarion, Inc. Announces Delayed 10-Q FilingMay 23, 2023 | finance.yahoo.comAclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MDMay 19, 2023 | msn.comAclarion gets $2M debt financingMay 19, 2023 | finance.yahoo.comAclarion Announces Non-Convertible Debt Financing to Achieve Three Critical CatalystsMay 10, 2023 | proactiveinvestors.comAclarion providing less invasive solution to treat lo back pain through augmented intelligenceApril 28, 2023 | finance.yahoo.comAclarion to Host Thought Leadership Symposium at SPINEWEEK 2023April 24, 2023 | ca.finance.yahoo.comAclarion, Inc. (ACON) Interactive Stock Chart - Yahoo FinanceApril 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 03:04 PM with a stated reason of "LULD pause."April 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 12:04 PM with a stated reason of "LULD pause."April 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 11:04 AM with a stated reason of "LULD pause."April 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 10:04 AM with a stated reason of "LULD pause."April 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 10:04 AM with a stated reason of "LULD pause." Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. ACON Media Mentions By Week ACON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACON News Sentiment▼0.020.42▲Average Medical News Sentiment ACON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACON Articles This Week▼20▲ACON Articles Average Week Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OpGen News Today Galmed Pharmaceuticals News Today Windtree Therapeutics News Today NanoVibronix News Today iSpecimen News Today Dynatronics News Today CNS Pharmaceuticals News Today Clearmind Medicine News Today ReShape Lifesciences News Today Allarity Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACON) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.